Last reviewed · How we verify
Probiotic Blend Chewable Tablet
This probiotic blend supports gut health by promoting beneficial bacteria.
This probiotic blend supports gut health by promoting beneficial bacteria. Used for Supports gut health in individuals with irritable bowel syndrome (IBS).
At a glance
| Generic name | Probiotic Blend Chewable Tablet |
|---|---|
| Also known as | Scaling and root debridement. |
| Sponsor | Dow University of Health Sciences |
| Drug class | Probiotic |
| Modality | Small molecule |
| Therapeutic area | Gastrointestinal |
| Phase | Phase 3 |
Mechanism of action
The probiotic blend contains a combination of live microorganisms that help maintain a healthy balance of gut flora, which can aid in digestion and boost the immune system.
Approved indications
- Supports gut health in individuals with irritable bowel syndrome (IBS)
Common side effects
- Gastrointestinal upset
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Probiotic Blend Chewable Tablet CI brief — competitive landscape report
- Probiotic Blend Chewable Tablet updates RSS · CI watch RSS
- Dow University of Health Sciences portfolio CI